(Q38324456)

2 September 2017

1 reference

title

Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach (English)

1 reference

2 September 2017

1 reference

neoplastic stem cells

1 reference

Sarandeep Malhi

1

1 reference

2 September 2017

Xiaochen Gu

series ordinal

2

1 reference

2 September 2017

language of work or name

English

0 references

publication date

20 January 2015

1 reference

Expert Opinion on Drug Delivery

2 September 2017

published in

1 reference

2 September 2017

volume

12

1 reference

2 September 2017

issue

7

1 reference

2 September 2017

page(s)

1177-1201

1 reference

Role of integrated cancer nanomedicine in overcoming drug resistance.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Cancer stem cells in solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Flow cytometry in cancer stem cell analysis and separation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

On the stem cell origin of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Understanding cancer stem cell heterogeneity and plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Cancer stem cells and drug resistance: the potential of nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Brain tumor stem cells: bringing order to the chaos of brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Chemotherapy dose--response relationships in non-small cell lung cancer and implied resistance mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Pharmacogenetics of ATP-binding cassette transporters and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Pharmacological strategies for overcoming multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Overexpression of CD133 promotes drug resistance in C6 glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Identification of cells initiating human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Can nanomedicines kill cancer stem cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

BCRP/ABCG2 confers anticancer drug resistance without covalent dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

DNA-damage response in tissue-specific and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Stems cells and the pathways to aging and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Cancer drug resistance: an evolving paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Cancer stem cell niche: the place to be

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Cancer stem cells and their niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Three-dimensional culture of mouse renal carcinoma cells in agarose macrobeads selects for a subpopulation of cells with cancer stem cell or cancer progenitor properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Breast cancer stem cells, cytokine networks, and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Understanding and targeting cancer stem cells: therapeutic implications and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Wnt signaling in stem and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Wnt signaling in adult intestinal stem cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Targeting Wnt signaling: can we safely eradicate cancer stem cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Unraveling the therapeutic potential of the Hedgehog pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Targeting Hedgehog--a cancer stem cell pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Metastatic stem cells: sources, niches, and vital pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Roles of TGF-beta family signaling in stem cell renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

BikDD eliminates breast cancer initiating cells and synergizes with lapatinib for breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

A restricted cell population propagates glioblastoma growth after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

ABC transporters in cancer: more than just drug efflux pumps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Mechanisms of acquired resistance to targeted cancer therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

CD44-targeted docetaxel conjugate for cancer cells and cancer stem-like cells: a novel hyaluronic acid-based drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

HPMA copolymer-based combination therapy toxic to both prostate cancer stem/progenitor cells and differentiated cells induces durable anti-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line: towards targeting of cancer stem cells with phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Selective inhibition of breast cancer stem cells by gold nanorods mediated plasmonic hyperthermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Prostate stem cell antigen antibody-conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in a mouse lung cancer stem cell model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

MicroRNA regulation of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

siRNA targeting Notch-1 decreases glioma stem cell proliferation and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

MicroRNA delivery by cationic lipoplexes for lung cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Lipid-based nanoparticle delivery of Pre-miR-107 inhibits the tumorigenicity of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Bimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

RNA aptamers targeting cancer stem cell marker CD133.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Nanoencapsulation of stem cells within polyelectrolyte multilayer shells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Immunotherapy: a useful strategy to help combat multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Notch signaling, gamma-secretase inhibitors, and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Hedgehog pathway as a drug target: Smoothened inhibitors in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

IFNalpha activates dormant haematopoietic stem cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Orthotopic glioblastoma stem-like cell xenograft model in mice to evaluate intra-arterial delivery of bevacizumab: from bedside to bench

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Hit 'em where they live: targeting the cancer stem cell niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Sensitization of pancreatic cancer stem cells to gemcitabine by Chk1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2015.998648

10.1517/17425247.2015.998648

21 January 2018

Identifiers

DOI

1 reference

release_lp67vajcdbgvhn3efc6otuapnu

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lp67vajcdbgvhn3efc6otuapnu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference